DrugPatentWatch Database Preview
Breckenridge Pharm Company Profile
What is the competitive landscape for BRECKENRIDGE PHARM, and what generic and branded alternatives to BRECKENRIDGE PHARM drugs are available?
BRECKENRIDGE PHARM has forty approved drugs.
Summary for Breckenridge Pharm
| US Patents: | 0 |
| Tradenames: | 34 |
| Ingredients: | 34 |
| NDAs: | 40 |
| Patent Litigation for Breckenridge Pharm: | See patent lawsuits for Breckenridge Pharm |
| PTAB Cases with Breckenridge Pharm as petitioner: | See PTAB cases with Breckenridge Pharm as petitioner |
Drugs and US Patents for Breckenridge Pharm
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Breckenridge Pharm | LEVETIRACETAM | levetiracetam | TABLET;ORAL | 090511-004 | Aug 18, 2011 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Breckenridge Pharm | LANSOPRAZOLE | lansoprazole | CAPSULE, DELAYED REL PELLETS;ORAL | 203964-002 | Oct 17, 2018 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Breckenridge Pharm | BENDAMUSTINE HYDROCHLORIDE | bendamustine hydrochloride | POWDER;IV (INFUSION) | 205447-001 | Dec 29, 2016 | AP | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Breckenridge Pharm | ENTECAVIR | entecavir | TABLET;ORAL | 208721-002 | Mar 15, 2018 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Breckenridge Pharm | MELOXICAM | meloxicam | TABLET;ORAL | 077920-001 | Jul 19, 2006 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Breckenridge Pharm | METHYLPHENIDATE HYDROCHLORIDE | methylphenidate hydrochloride | TABLET, CHEWABLE;ORAL | 204954-002 | Jan 26, 2017 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Paragraph IV (Patent) Challenges for BRECKENRIDGE PHARM drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Delayed-release Tablets | 20 mg | ➤ Subscribe | 2015-06-03 |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
